Cheng‐Bo Han
Sungshin Women's University(KR)Peking University(CN)Lanzhou Jiaotong University(CN)Heilongjiang University(CN)China Medical University(CN)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Lung Cancer Research Studies, Cancer Immunotherapy and Biomarkers, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Concurrent Genetic Alterations and Other Biomarkers Predict Treatment Efficacy of EGFR-TKIs in EGFR-Mutant Non-Small Cell Lung Cancer: A Review(2020)85 cited
- → Concordant KRAS Mutations in Primary and Metastatic Colorectal Cancer Tissue Specimens: A Meta-Analysis and Systematic Review(2012)71 cited
- → Neoadjuvant EGFR-TKI Therapy for EGFR-Mutant NSCLC: A Systematic Review and Pooled Analysis of Five Prospective Clinical Trials(2021)65 cited
- → Meta-analysis of the impact of de novo and acquired <em>EGFR</em> T790M mutations on the prognosis of patients with non-small cell lung cancer receiving EGFR-TKIs(2017)52 cited
- → Circlular RNA BARD1 (Hsa_circ_0001098) overexpression in breast cancer cells with TCDD treatment could promote cell apoptosis via miR-3942/BARD1 axis(2018)49 cited
- → Targeting mitochondria: restoring the antitumor efficacy of exhausted T cells